Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Critical Reviews in Oncology/Hematology|July 6, 2025
Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancerGiuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
International Journal of Molecular Sciences|June 22, 2017
New Insights in Thyroid Cancer and p53 Family ProteinsLivia Manzella, Stefania Stella, Maria Stella Pennisi, et al.
Frontiers in Oncology|August 30, 2024
REThinking the role of the RET oncogene in breast cancerGiuseppe Di Grazia, Chiara Conti, Sabrina Nucera, et al.
Molecular and Cellular Endocrinology|August 8, 2022
Comparative proteomic analysis of insulin receptor isoform A and B signalingRoberta Malaguarnera, Caterina Gabriele, Gianluca Santamaria, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 4, 2013
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoproteinPietro Buffa, Chiara Romano, Alessandro Pandini, et al.
Plos One|October 17, 2015
Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C ReleaseYuki Ishii, May Keu Nhiayi, Edison Tse, et al.
Pathology, Research and Practice|May 23, 2024
Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution seriesGiuseppe Broggi, Michele Massimino, Maria Failla, et al.
Scientific Reports|July 1, 2025
Novel protocol for mapping virus integration sites in genes involved in therapy resistanceMichele Massimino, Zhangzan Huang, Jean Helmijr, et al.
Frontiers in Pharmacology|April 8, 2026
Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIsMichele Massimino, Elena Tirrò, Chiara Romano, et al.
Frontiers in Endocrinology|June 29, 2026
Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancerGiulia Sapuppo, Marco Russo, Grete Francesca Privitera, et al.
Pageof 7